Deficient immune response to Mycoplasma pneumoniae in childhood asthma

Allergy and Asthma Proceedings

Volumn 30, Issue 2, 2009, Pages 158-165

  Atkinson, T Prescott ^a   Duffy, Lynn B ^b   Pendley, Donna ^a   Dai, Yuling ^a   Cassell, Gail H ^c  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Airway inflammation; Antibodies; Asthma; Children; Cytokines; Immune response; Infection; Interferon; Mycoplasma

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY TITER; ARTICLE; ASTHMA; BACTERIUM CULTURE; CELL PROLIFERATION; CELLULAR IMMUNE DEFICIENCY; CELLULAR IMMUNITY; CHILD; CHILDHOOD; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNE DEFICIENCY; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; SCHOOL CHILD; SEROLOGY; ADOLESCENT; BLOOD; FOLLOW UP; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; PREVALENCE; PROSPECTIVE STUDY; SECRETION;

ADOLESCENT; ANTIGENS, BACTERIAL; ASTHMA; CELL PROLIFERATION; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; PREVALENCE; PROSPECTIVE STUDIES;

EID: 67650477661     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2009.30.3207     Document Type: Article

References (51)

1. Yavlovich A, Tarshis M, and Rottem S. Internalization and intracellular survival of Mycoplasma pneumoniae by non-phagocytic cells. FEMS Microbiol Lett 233:241-246, 2004.
2. Dallo SF, and Baseman JB. Intracellular DNA replication and long-term survival of pathogenic mycoplasmas. Microb Pathog 29:301-309, 2000.
3. Meseguer MA, Alvarez A, Rejas MT, et al. Mycoplasma pneumoniae: A reduced-genome intracellular bacterial pathogen. Infection. Genet Evol 3:47-55, 2003.
4. Fernald GW, Clyde WA Jr, and Denny FW. Nature of the immune response to Mycoplasma pneumoniae. J Immunol 98:1028-1038, 1967.
5. Biberfeld G. Distribution of antibodies within 19 S and 7 S immunoglobulins following infection with Mycoplasma pneumoniae. J Immunol 100:338-347, 1968.
6. Annagur A, Kendirli SG, Yilmaz M, et al. Is there any relationship between asthma and asthma attack in children and atypical bacterial infections; Chlamydia pneumoniae, Mycoplasma pneumoniae, and Helicobacter pylori. J Trop Pediatr 53:313-318, 2007.
7. Biscardi S, Lorrot M, Marc E, et al. Mycoplasma pneumoniae and asthma in children. Clin Infect Dis 38:1341-1346, 2004.
8. Lieberman D, Lieberman D, Printz S, et al. Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med 167:406-410, 2003.
9. Rossi OV, Kinnula VL, Tuokko H, et al. Respiratory viral and mycoplasma infections in patients hospitalized for acute asthma. Monaldi Arch Chest Dis 49:107-111, 1994.
10. Yano T, Ichikawa Y, Komatu S, et al. Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma. Am J Respir Crit Care Med 149:1348-1353, 1994.
11. Seggev JS, Lis I, Siman-Tov R, et al. Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults. Ann Allergy 57:263-265, 1986.
12. Wilsher ML, and Kolbe J. Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma. Am J Respir Crit Care Med 151:579-580, 1995.
13. Marc E, Chaussain M, Moulin F, et al. Reduced lung diffusion capacity after Mycoplasma pneumoniae pneumonia. Pediatr Infect Dis J 19:706-710, 2000.
14. Wongtim S, and Mogmued S. Methacholine inhalation challenge in patients with post-Mycoplasma pneumoniae pneumonia. Asian Pac J Allergy Immunol 13:5-10, 1995.
15. Sabato AR, Martin AJ, Marmion BP, et al. Mycoplasma pneumoniae: Acute illness, antibiotics, and subsequent pulmonary function. Arch Dis Child 59:1034-1037, 1984.
16. Mok JY, Waugh PR, and Simpson H. Mycoplasma pneumoniae infection. A follow-up study of 50 children with respiratory illness. Arch Dis Child 54:506-511, 1979.
17. Kjaer BB, Jensen JS, Nielsen KG, et al. Lung function and bronchial responsiveness after Mycoplasma pneumoniae infection in early childhood. Pediatr Pulmonol 43:567-575, 2008.
18. Gil JC, Cedillo RL, Mayagoitia BG, et al. Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann Allergy 70:23-25, 1993.
19. Teig N, Anders A, Schmidt C, et al. Chlamydophila pneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases. Thorax 60:962-966, 2005.
20. Kraft M, Cassell GH, Henson JE, et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 158:998-1001, 1998.
21. Johnston SL. Macrolide antibiotics and asthma treatment. J Allergy Clin Immunol 117:1233-1236, 2006.
22. Kostadima E, Tsiodras S, Alexopoulos EI, et al. Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma. Eur Respir J 23:714-717, 2004.
23. Piacentini GL, Peroni DG, Bodini A, et al. Azithromycin reduces bronchial hyperresponsiveness and neutrophilic airway inflammation in asthmatic children: A preliminary report. Allergy Asthma Proc 28:194-198, 2007.
24. Ekici A, Ekici M, and Lu AK. Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma. J Asthma 39:181-185, 2002.
25. Amayasu H, Yoshida S, Ebana S, et al. Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. Ann Allergy Asthma Immunol 84:594-598, 2000.
26. Garey KW, Rubinstein I, Gotfried MH, et al. Long-term clarithromycin decreases prednisone requirements in elderly patients with prednisone-dependent asthma. Chest 118:1826-1827, 2000.
27. Healy DP. Macrolide immunomodulation of chronic respiratory diseases. Curr Infect Dis Rep 9:7-13, 2007.
28. Lopez-Boado YS, and Rubin BK. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases. Curr Opin Pharmacol 8:286-291, 2008.
29. Kraft M, Cassell GH, Pak J, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: Effect of clarithromycin. Chest 121:1782-1788, 2002.
30. Gerald LB, Grad R, Turner-Henson A, et al. Validation of a multistage asthma case-detection procedure for elementary school children. Pediatrics 114:e459-e468, 2004.
31. Cassell GH, Blanchard A, Duffy L, et al. Mycoplasmas. In Clinical and Pathogenic Microbiology. Howard BJ, Klaas J III, Rubin SJ, et al, (Eds). St. Louis: Mosby Yearbook, Inc., 491-502, 1994.
32. Cassell GH, Gambill G, and Duffy L. ELISA in respiratory infections of humans. In Molecular and Diagnostic Procedures in Mycoplasmology. Tully JG, and Razin S (Eds). New York: Academic Press, 123-136, 1996.
33. Hamvas RM, Johnson M, Vlieger AM, et al. Role for mannose binding lectin in the prevention of mycoplasma infection. Infect Immun 73:5238-5240, 2005.
34. Bredt W, Kist M, and Jacobs E. Phagocytosis and complement action. Isr J Med Sci 17:637-640, 1981.
35. Bredt W, and Bitter-Suermann D. Interactions between Mycoplasma pneumoniae and guinea pig complement. Infect Immun 11:497-504, 1975.
36. Brunner H, Kalica AR, James WD, et al. Ultrastructural lesions in Mycoplasma pneumoniae membranes produced by antibody and complement. Infect Immun 7:259-264, 1973.
37. Brunner H, Razin S, Kalica AR, et al. Lysis and death of Mycoplasma pneumoniae by antibody and complement. J Immunol 106:907-916, 1971.
38. Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 17(suppl 1):S37-S46, 1993.
39. Roifman CM, Rao CP, Lederman HM, et al. Increased susceptibility to mycoplasma infection in patients with hypogamma-globulinemia. Am J Med 80:590-594, 1986.
40. Kanamori M, Katsura T, Ishiyama N, et al. Immune responses in Mycoplasma pneumoniae infection of infant mouse and of man. Isr J Med Sci 23:568-573, 1987.
41. Merrell DS, and Falkow S. Frontal and stealth attack strategies in microbial pathogenesis. Nature 430:250-256, 2004.
42. Hoekstra MO, Hoekstra Y, De Reus D, et al. Interleukin-4, interferon-gamma and interleukin-5 in peripheral blood of children with moderate atopic asthma. Clin Exp Allergy 27:1254-1260, 1997.
43. Stern DA, Guerra S, Halonen M, et al. Low IFN-gamma production in the first year of life as a predictor of wheeze during childhood. J Allergy Clin Immunol 120:835-841, 2007.
44. Snapper CM, and Paul WE. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944-947, 1987.
45. Huang S, Hendriks W, Althage A, et al. Immune response in mice that lack the interferon-gamma receptor. Science 259:1742-1745, 1993.
46. Dalton DK, Pitts-Meek S, Keshav S, et al. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739-1742, 1993.
47. Rosenzweig SD, and Holland SM. Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev 203:38-47, 2005.
48. Wu Q, Martin RJ, Lafasto S, et al. Toll-like receptor 2 down-regulation in established mouse allergic lungs contributes to decreased mycoplasma clearance. Am J Respir Crit Care Med 177:720-729, 2008.
49. Chaplin DD, Zindl CL, Duffy LB, et al. Clearance of Mycoplasma pneumoniae is impaired in mice with established allergic airway inflammation. J Allergy Clin Immunol 119:S132, 2007 (Abs).
50. Wu Q, Martin RJ, Rino JG, et al. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect 9:78-86, 2007.
51. Platts-Mills TA. The role of immunoglobulin E in allergy and asthma. Am J Respir Crit Care Med 164:S1-S5, 2001.